Abiopharma

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: SpringWorks Therapeutics, Inc. - common stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Inozyme Pharma, Inc. - Common Stock.

Best Printer Deals In 2025

Great GPUs and VR Equipment For PC Virtual Reality

Best Ring Lights and Video LED Panels In 2025

Granting of Stock Options and Vesting of Restricted Share Units

New Form 144 - GeneDx Holdings Corp. Filed: 2025-07-01 AccNo: 0001818331-25-000096 Size: 13 KB

New Form 144 - GeneDx Holdings Corp. Filed: 2025-07-01 AccNo: 0001818331-25-000095 Size: 11 KB

Granting of Stock Options and Vesting of Restricted Share Units

Úthlutun nýrra kauprétta og afhending áunninna hlutabréfaréttinda

New Form SCHEDULE 13D/A - BridgeBio Pharma, Inc. Filed: 2025-07-01 AccNo: 0000905148-25-002298 Size: 52 KB

New Form 4 - BridgeBio Pharma, Inc. Filed: 2025-07-01 AccNo: 0000905148-25-002297 Size: 17 KB

New Form 4 - WEST PHARMACEUTICAL SERVICES INC Filed: 2025-07-01 AccNo: 0000105770-25-000055 Size: 5 KB

New Form SCHEDULE 13D - Alaunos Therapeutics, Inc. Filed: 2025-07-01 AccNo: 0000921895-25-001912 Size: 23 KB

New Form 144 - Athira Pharma, Inc. Filed: 2025-07-01 AccNo: 0001415889-25-018810 Size: 4 KB